TP53 and cancer: Based on the findings of this manuscript, the following genes and pathways should be investigated for preclinical studies as they are significant to cancer biology; the tumour suppressors p21 and p53 as well as the following pathways: NF-κB, AKT, PI3K, p38-MAPK pathways.